About
Research
Patient Care
Education & Training
Community
Jun 20, 2023
FDA Approves New Drug Combo For Prostate Cancer
Alexandre Chan, PharmD, MPH, professor of clinical pharmacy at the School of Pharmacy & Pharmaceutical Sciences at University of California, Irvine is similarly excited about the prospect of this combination of medications being better understood and implemented. “I think that’s good news for patients, in the sense that there are additional therapies that we can use at first line and [they] have demonstrated that if you have the proper mutations, you get much better progression free and also overall survival.”
Jun 14, 2023
Adjusting Your Body Clock May Stave Off Cancer
For some time now epidemiological studies of night-shift workers have linked disruptions in circadian rhythms to cancer and other diseases. … “We're starting to understand the reasons these things happen,” says Selma Masri, a circadian biologist and assistant professor at the University of California, Irvine, who has shown how circadian disruption pushes colon cancer progression by interfering with the way certain genes are expressed.
Jun 09, 2023
Rise in colorectal cancer among young adults an alarming trend
The rise in colon cancer rates among millennials has been alarming. "Physicians are aware, primary care doctors are aware, oncologists are aware, and I am not sure the public is aware that it is a real issue," said Dr. Jason Zell, at UCI Health Chao Family Comprehensive Cancer Center and UCI associate professor.
Jun 06, 2023
Jung In Park, University of California, Irvine – Survival Machine Learning for Breast Cancer Patients
Racial disparities can exist even in machine learning. Jung In Park, assistant professor in the Sue & Bill Gross School of Nursing at the University of California, Irvine, finds a way to tackle biases and make a difference for vulnerable populations
Mar 09, 2023
Kickass Women at UC Irvine - Dr. Sora Park Tanjasiri
After teaching at Cal State Fullerton for 15 years, Tanjasiri was recruited by the Chao Family Comprehensive Cancer Center, one of only 51 cancer centers nationwide funded by the National Cancer Institute. She’s spent her career focused on cancer research and prevention, particularly in communities of color who are at the greatest risk.
Jan 31, 2023
The Caris Precision Oncology Alliance Welcomes The UCI Health Chao Family Comprehensive Cancer Center
Caris Life Sciences®(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced today that the UCI Health Chao Family Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™ (POA). The POA is a growing network of leading cancer centers across the globe that collaborate to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize standards of care for molecular testing through innovative research focused on predictive and prognostic markers that improve the clinical outcomes for cancer patients.
Jun 24, 2022
Elizabeth Brem, MD, on Frontline Management of CLL
In the last few years, frontline management of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) has undergone a profound paradigm shift. First-line treatment with novel targeted therapies has become preferable to the use of chemoimmunotherapy regimens such as fludarabine, cyclophosphamide, and rituximab (FCR) -- the latter being largely reserved for patients younger than 65 with no comorbidities, and no 17p deletion or other TP53 mutations.
Dec 21, 2021
Virus-based sensor detects bladder cancer markers in urine
Researchers have made a virus-based biosensor that detects markers of bladder cancer in urine. Their goal is to make a dipstick that can quickly detect bladder cancer as part of routine urinalysis.
Oct 21, 2021
NPR Academic Minute - "Follow-Up Care for Young Adult Cancer Survivors"
On University of California, Irvine Week: Lifelong follow up care is critical for young cancer survivors. Joel Milam, professor of epidemiology, examines why. Joel Milam, PhD, is a professor of epidemiology and biostatistics at the University of California, Irvine's Program in Public Health. He also has an adjunct appointment at the UCI School of Medicine's Department of Hematology/Oncology. Dr. Milam's research focuses on young adult cancer survivorship, positive psychology, and HIV prevention/control. Dr. Milam's interest in cancer research led him to become the Co-Leader of the Cancer Control Program at the Chao Family Comprehensive Cancer Center, where he facilitates research to identify and reduce cancer risk, and improve quality of life throughout the cancer care trajectory. Aside from teaching at UCI, Dr. Milam is a Co-Founder & Co-Director of the Center for Young Adult Cancer Survivorship Research. The Center is an interdisciplinary collaborative, including affiliate faculty, trainees, and patient advocates at UCI and USC.
Oct 20, 2021
NPR Academic Minute - "The Central Role of Social Support in the Health of Chinese and Korean American Immigrants"
Immigrants can thrive with a strong support network. Brittany Morey, assistant professor of health, society and behavior, explores why. Brittany N. Morey, PhD, MPH, is an Assistant Professor of Public Health at University of California, Irvine.